The neurochemical mechanism of rebound psychosis in Parkinson's disease.
Papapetropoulos
Spiridon
S
Department of Neurology, University of Miami School of Medicine, Miami, Florida.
Mash
Deborah C
DC
Department of Neurology, University of Miami School of Medicine, Miami, Florida.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D003987:Dibenzothiazepines / Q000009:adverse effects*; D006801:Humans; D010300:Parkinson Disease / Q000523:psychology*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology; D000069348:Quetiapine Fumarate
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D003024:Clozapine